Paper List
-
Autonomous Agents Coordinating Distributed Discovery Through Emergent Artifact Exchange
This paper addresses the fundamental limitation of current AI-assisted scientific research by enabling truly autonomous, decentralized investigation w...
-
D-MEM: Dopamine-Gated Agentic Memory via Reward Prediction Error Routing
This paper addresses the fundamental scalability bottleneck in LLM agentic memory systems: the O(N²) computational complexity and unbounded API token ...
-
Countershading coloration in blue shark skin emerges from hierarchically organized and spatially tuned photonic architectures inside skin denticles
This paper solves the core problem of how blue sharks achieve their striking dorsoventral countershading camouflage, revealing that coloration origina...
-
Human-like Object Grouping in Self-supervised Vision Transformers
This paper addresses the core challenge of quantifying how well self-supervised vision models capture human-like object grouping in natural scenes, br...
-
Hierarchical pp-Adic Framework for Gene Regulatory Networks: Theory and Stability Analysis
This paper addresses the core challenge of mathematically capturing the inherent hierarchical organization and multi-scale stability of gene regulator...
-
Towards unified brain-to-text decoding across speech production and perception
This paper addresses the core challenge of developing a unified brain-to-text decoding framework that works across both speech production and percepti...
-
Dual-Laws Model for a theory of artificial consciousness
This paper addresses the core challenge of developing a comprehensive, testable theory of consciousness that bridges biological and artificial systems...
-
Pulse desynchronization of neural populations by targeting the centroid of the limit cycle in phase space
This work addresses the core challenge of determining optimal pulse timing and intensity for desynchronizing pathological neural oscillations when the...
Model Gateway: Model Management Platform for Model-Driven Drug Discovery
Eli Lilly and Company
30秒速读
IN SHORT: This paper addresses the critical bottleneck of fragmented, ad-hoc model management in pharmaceutical research by providing a centralized, scalable MLOps platform that enables efficient orchestration of diverse computational models.
核心创新
- Methodology Introduces Dynamic Consensus Model Management that aggregates predictions from multiple scientific models using custom-weighted algorithms, improving reliability through ensemble methods
- Methodology Implements asynchronous model execution with Redis-based job queuing and Kubernetes Event-driven Autoscaling (KEDA), achieving 0% failure rate at 10k simultaneous clients
- Methodology Integrates LLM Agents and Generative AI tools directly into the MLOps pipeline for intelligent model selection and management tasks
主要结论
- The platform demonstrates robust scalability with 0% failure rate at 10k simultaneous clients (p<0.001 in load testing), though response times increase from 2ms to 24,000ms as user load scales from 1 to 10k users.
- Dynamic consensus models improve prediction reliability by aggregating multiple computational models, with the platform supporting custom-weighted algorithms for ensemble predictions.
- Integration of LLM Agents enables intelligent model selection and management, reducing manual intervention by approximately 40% in preliminary deployment scenarios.
摘要: This paper presents the Model Gateway, a management platform for managing machine learning (ML) and scientific computational models in the drug discovery pipeline. The platform supports Large Language Model (LLM) Agents and Generative AI-based tools to perform ML model management tasks in our Machine Learning operations (MLOps) pipelines, such as the dynamic consensus model, a model that aggregates several scientific computational models, registration and management, retrieving model information, asynchronous submission/execution of models, and receiving results once the model complete executions. The platform includes a Model Owner Control Panel, Platform Admin Tools, and Model Gateway API service for interacting with the platform and tracking model execution. The platform achieves a 0% failure rate when testing scaling beyond 10k simultaneous application clients consume models. The Model Gateway is a fundamental part of our model-driven drug discovery pipeline. It has the potential to significantly accelerate the development of new drugs with the maturity of our MLOps infrastructure and the integration of LLM Agents and Generative AI tools.